Compound Evidence File
#EC-2026-0835
P2NP (1-phenyl-2-nitropropene) CAS 705-60-2
Filed under Raw Materials. The bureau holds 123 laboratory returns for this compound from 42 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
42 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Jan 2026 | 16 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Jun 2026 | 24 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 9.9 | 10.0 | 16 Nov 2025 | 7 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 10.0 | 10.0 | 7 Mar 2026 | 14 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 10.0 | 10.0 | 12 Mar 2026 | 3 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 6 Jun 2026 | 14 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Mar 2026 | 25 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Jan 2026 | 26 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 18 May 2026 | 1 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 10 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 28 Mar 2026 | 4 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 9.9 | 23 Mar 2026 | 23 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 18 May 2026 | 3 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 9.9 | 9.9 | 10.0 | 22 Apr 2026 | 5 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Jun 2026 | 10 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 10.0 | 5 Mar 2026 | 11 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 9.9 | 8 Jun 2026 | 23 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Jun 2026 | 10 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Apr 2026 | 6 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 26 Apr 2026 | 21 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 9.9 | 6 Dec 2025 | 4 May 2026 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 1 | 9.0 | 9.0 | 9.0 | 7 May 2025 | 7 May 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.9 | 8.0 | 9.8 | 21 May 2026 | 21 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 8.3 | 8.2 | 8.4 | 24 May 2026 | 24 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 8.3 | 8.3 | 8.3 | 13 Feb 2025 | 13 Feb 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.0 | 7.0 | 9.2 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 7.9 | 6.1 | 9.6 | 25 May 2026 | 25 May 2026 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 7.6 | 7.6 | 7.6 | 25 Apr 2025 | 25 Apr 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 7.1 | 6.0 | 8.5 | 24 May 2026 | 24 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 7.1 | 7.1 | 7.1 | 3 Jun 2025 | 3 Jun 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 3 | 6.8 | 5.0 | 10.0 | 3 Jul 2025 | 17 May 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 3 | 6.5 | 4.7 | 9.5 | 13 Jun 2025 | 20 May 2026 |
| Elite Research USACASE #VI-2026-0267 | X | 2 | 5.2 | 5.0 | 5.5 | 6 May 2025 | 20 May 2026 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 5.0 | 5.0 | 5.0 | 16 Mar 2025 | 16 Mar 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 2 | 4.8 | 4.2 | 5.4 | 13 Jun 2025 | 24 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 4.2 | 4.2 | 4.2 | 20 Jun 2025 | 20 Jun 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 4.2 | 4.2 | 4.2 | 24 Apr 2025 | 24 Apr 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 4.1 | 4.1 | 4.1 | 28 Mar 2025 | 28 Mar 2025 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 2.8 | 2.8 | 2.8 | 11 Jun 2025 | 11 Jun 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
Open any subject to view the batch-level evidence for P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 alone.